Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-α in chronic hepatitis C

被引:23
作者
Fabris, C [1 ]
Soardo, G [1 ]
Falleti, E [1 ]
Toniutto, P [1 ]
Vitulli, D [1 ]
Federico, E [1 ]
Del Forno, M [1 ]
Mattiuzzo, M [1 ]
Gonano, F [1 ]
Pirisi, M [1 ]
机构
[1] Univ Udine, Dept Expt & Clin Pathol & Med, Cattedra Med Interna, I-33100 Udine, Italy
关键词
D O I
10.1089/jir.1998.18.705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To investigate the relationship among circulating cytokines, inflammation in the liver, and kind of response to interferon-alpha (IFN-alpha) in hepatitis C, we studied 63 consecutive patients (38 male, 25 female), treated with IFN for up to 1 year. Serum tumor necrosis factor-alpha (TNF-alpha) was measured at baseline and after 3 months of treatment, Transient (TR) or sustained response (SR) was observed in 29 and 16 patients, respectively. Baseline levels of TNF less than or equal to 22 ng/L were observed in 69% of patients with SR, 55% of patients with TR, and 22% of nonresponders (p < 0.01). There was a significant correlation between baseline TNF levels and histologic grading score of hepatitis (p < 0.01), After 3 months of treatment, TNF levels >22 ng/L were observed in 63% of patients with SR, 69% of patients with TR, and 83% of nonresponders (p NS), Independent of the treatment outcome, TNF levels were lower at baseline and increased significantly with treatment in patients with lower histologic grading (p < 0.005), In conclusion, in patients with chronic hepatitis C, circulating TNF levels correlate with the degree of inflammation in the liver. Response to IFN is accompanied by an inflammatory response involving the release of TNF.
引用
收藏
页码:705 / 709
页数:5
相关论文
共 25 条
[1]   INVITRO EFFECTS OF LYMPHOBLASTOID INTERFERON ON LYMPHOCYTE-ACTIVATION AND CELL-MEDIATED CYTOLYSIS IN PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION [J].
ALEXANDER, GJM ;
NOURIARIA, KT ;
NEUBERGER, J ;
BAKHTIAR, M ;
VOGEL, W ;
ANDERSON, MG ;
MAGRIN, S ;
EDDLESTON, ALWF ;
WILLIAMS, R .
JOURNAL OF HEPATOLOGY, 1986, 3 :S269-S277
[2]   EPIDEMIOLOGY OF HEPATITIS-C IN THE WEST [J].
ALTER, MJ .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :5-14
[3]   Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa [J].
Cacciarelli, TV ;
Martinez, OM ;
Gish, RG ;
Villanueva, JC ;
Krams, SM .
HEPATOLOGY, 1996, 24 (01) :6-9
[4]  
CHISARI FV, 1995, HEPATOLOGY, V22, P1316, DOI 10.1016/0270-9139(95)90645-2
[5]  
CONJEEVARAM HS, 1995, HEPATOLOGY, V22, P1326, DOI 10.1002/hep.1840220444
[6]   SPONTANEOUS PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1-BETA DURING INTERFERON-ALPHA TREATMENT OF CHRONIC HBV INFECTION [J].
DANIELS, HM ;
MEAGER, A ;
EDDLESTON, ALWF ;
ALEXANDER, GJM ;
WILLIAMS, R .
LANCET, 1990, 335 (8694) :875-877
[7]   Factors predictive of a beneficial response to therapy of hepatitis C [J].
Davis, GL ;
Lau, JYN .
HEPATOLOGY, 1997, 26 (03) :S122-S127
[8]   THERAPY OF HEPATITIS-C [J].
FRIED, MW ;
HOOFNAGLE, JH .
SEMINARS IN LIVER DISEASE, 1995, 15 (01) :82-91
[9]   ASSESSMENT OF HEPATITIS-C VIRUS-RNA LEVELS BY QUANTITATIVE COMPETITIVE RNA-POLYMERASE CHAIN-REACTION - HIGH-TITER VIREMIA CORRELATES WITH ADVANCED-STAGE OF DISEASE [J].
GRETCH, D ;
COREY, L ;
WILSON, J ;
DELAROSA, C ;
WILLSON, R ;
CARITHERS, R ;
BUSCH, M ;
HART, J ;
SAYERS, R ;
HAN, J .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1219-1225
[10]   To kill or to cure: Options in host defense against viral infection [J].
Guidotti, LG ;
Chisari, FV .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :478-483